ANRO

Alto Neuroscience Stock Analysis

AI Rating

Good
  • Quality4/10
  • Growth↓ 3/10
  • Value↑ 5/10
Alto Neuroscience sales and earnings growth
ANRO Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 12.40%
  • FCF Y/Y↓ -4.63%
Alto Neuroscience gross and profit margin trends
ANRO Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 0.00%
Alto Neuroscience net debt vs free cash flow
ANRO Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -24.6

Alto Neuroscience stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗